Get informed when a big investor buys or sells
+ Follow9.33%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for APCO.BK is 9.33%. That is below the sector sector average of 11.3%. Investors often review this figure alongside Asian Phytoceuticals Public Ltd.'s historical trend and sector peers before judging valuation or financial health.
Against its sector companies, APCO.BK currently prints 9.33% for ROE, while the sector average sits near 11.3%. That is roughly 17.4% below the sector mean. Large gaps often invite a closer look at Asian Phytoceuticals Public Ltd.'s growth, margins, and balance sheet.
Return on Equity shows how effectively Asian Phytoceuticals Public Ltd. converts resources into returns. At 9.33%, APCO.BK may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting APCO.BK's ROE (9.33%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.